Contents:

I. INTRODUCTION Report Scope and Methodology Executive Summary II. BUSINESS ENVIRONMENT Economic Outlook Key Economic Indicators Industrial Output Population and Labor Foreign Investment Foreign Trade Financial and Tax Regulations Banking System and Regulations Foreign Exchange Taxes, Tariff and Custom Duties III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS Breast Cancer Treatment Drug Industry Structure Market Size Market Growth Driver Breast Cancer Treatment Drug Sales Volume Major Producer Facility Locations Major Producers’ Sales Volume and Market Share Labor Cost Potential Entrants Major Distributors Major Foreign Investments Technology Development IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND Overview Breast Cancer Treatment Drugs Sales Volume Chemotherapeutic Drug Paclitaxel Fluoropyrimidines Anthracycline Antibiotics Targeted Therapy Drug Therapertic Antibody Small Molecules Drug Aromatase Inhibitors (Targeted Therapy Drug) Endocrine Therapy Drug Anti-estrogens Progesterone Aromatase Inhibitors (Endocrine Therapy Drug) LH-RH Breast Cancer Treatment Drugs Import Chemotherapeutic Drug Paclitaxel Fluoropyrimidines Anthracycline Antibiotics Targeted Therapy Drug Therapertic Antibody Small Molecules Drug Aromatase Inhibitors (Targeted Therapy Drug) Endocrine Therapy Drug Anti-estrogens Progesterone Aromatase Inhibitors (Endocrine Therapy Drug) LH-RH Pricing Trend V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations Health Care Insurance Industry Overview Consumer Spending Trends Demographic Trends Health Care Industry Trends Hospitals and Hospital Beds Physicians and Physician Visits VI. MARKET ENTRY CHANNELS China Market Entry Overview China’s Distribution System Breast Cancer Treatment Drug Distribution Channels Transportation and Freight Infrastructure Communications China’s Market Entry Export to China Indirect export Direct Export License and Contract Manufacture Assembling in China Contract Manufacturing Trade Permit Investment Equity Joint Venture Contractual Joint Venture Wholly Foreign-Owned Enterprise VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY Breast Cancer Treatment Drug Producer Profiles and Directory LIST OF TABLES I. INTRODUCTION Economic Outlook Summary II. BUSINESS ENVIRONMENT Key Economic Indicators Industrial Output Population and Labor Force Trends Foreign Investment and Loans Foreign Trade III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS Breast Cancer Treatment Drug Sales Volume Major Producer Facility Locations Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share Major Foreign Investments IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND Total Breast Cancer Treatment Drugs Sales Volume Breast Cancer Treatment Drug Major Producer and Their Market Share Chemotherapeutic Drug Major Producer and Their Market Share Paclitaxel Major Producer and Their Market Share Fluoropyrimidines Major Producer and Their Market Share Anthracycline Antibiotics Major Producer and Their Market Share Targeted Therapy Drug Major Producer and Their Market Share Therapertic Antibody Major Producer and Their Market Share Small Molecules Drug Major Producer and Their Market Share Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share Endocrine Therapy Drug Major Producer and Their Market Share Anti-estrogens Major Producer and Their Market Share Progesterone Major Producer and Their Market Share Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share LH-RH Major Producer and Their Market Share Breast Cancer Treatment Drugs Import V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK Consumer Spending Trends Demographic Trends Health Care Industry Trends Hospitals and Hospital Beds Physicians and Physician Visits LIST OF CHARTS I. INTRODUCTION Breast Cancer Treatment Drug Sales Volume II. BUSINESS ENVIRONMENT China’s GDP and Growth Rate Industrial Output by Ownership China’s Imports and Exports III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS Chemotherapeutic Drug Sales Volume by Drugs Classification Targeted Therapy Drug Sales Volume by Drugs Classification Endocrine Therapy Drug Sales Volume by Drugs Classification Breast Cancer Treatment Drug Sales Volume IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND Breast Cancer Treatment Drug Sales Volume Chemotherapeutic Drug Sales Volume and Market Share Chemotherapeutic Drug Sales Volume by Drugs Classification Paclitaxel Sales Volume and Market Share Fluoropyrimidines Sales Volume and Market Share Anthracycline Antibiotics Sales Volume and Market Share Targeted Therapy Drug Sales Volume and Market Share Targeted Therapy Drug Sales Volume by Drugs Classification Therapertic Antibody Sales Volume and Market Share Small Molecules Drug Sales Volume and Market Share Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share Endocrine Therapy Drug Sales Volume and Market Share Endocrine Therapy Sales Volume by Drugs Classification Anti-estrogens Sales Volume and Market Share Progesterone Sales Volume and Market Share Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share LH-RH Sales Volume and Market Share Breast Cancer Treatment Drugs Import Chemotherapeutic Drug Import and Market Share Chemotherapeutic Drug Import by Drugs Classification Paclitaxel Import and Market Share Fluoropyrimidines Import and Market Share Anthracycline Antibiotics Import and Market Share Targeted Therapy Drug Import and Market Share Targeted Therapy Drug Import by Drugs Classification Therapertic Antibody Import and Market Share Small Molecules Drug Import and Market Share Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share Endocrine Therapy Drug Import and Market Share Endocrine Therapy Drug Import by Drugs Classification Anti-estrogens Import and Market Share Progesterone Import and Market Share Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share LH-RH Import and Market Share V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK VI. MARKETING STRATEGIES China’s Distribution Channel